<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhang L</submitter><funding>Guangdong Medical Science Foundation</funding><funding>National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><funding>the Natural Science Foundation of Guangdong Province</funding><pagination>178</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12918463</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(1)</volume><pubmed_abstract>Photodynamic therapy (PDT) is an effective adjunct treatment for oral squamous cell carcinoma (OSCC). Enhancing photosensitizer targeting and inducing effective cytotoxic T-cell responses through photoimmunotherapy have become key strategies to improve PDT efficacy. Migrasomes, as vesicular structures assembled by TSPAN4 and cholesterol microdomains, are implicated in immune escape and are emerging as sensitization targets for PDT. Here, we report a biomimetic nanoplatform, MOF-919@CCM, that combines enhanced tumor-cell membrane adhesion with light-controlled cholesterol degradation. Cloaking with a homologous cancer-cell membrane (CCM) imparts specific adhesion to tumor cells and improves targeted delivery of the photosensitizer. Moreover, the transition-metal nodes of MOF-919 exhibit per</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Migrasomes constrained by a homologous-targeting photodynamic nanoplatform: enhancing intratumoral CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T-cell-associated antitumor immunity in oral squamous cell carcinoma.</pubmed_title><pmcid>PMC12918463</pmcid><funding_grant_id>82373255</funding_grant_id><funding_grant_id>2024A1515012918</funding_grant_id><funding_grant_id>82501230</funding_grant_id><funding_grant_id>82571048</funding_grant_id><funding_grant_id>557A2025238</funding_grant_id><funding_grant_id>2025A1515010769</funding_grant_id><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Shi F</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Jia W</pubmed_authors><pubmed_authors>Yu D</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Gao H</pubmed_authors><pubmed_authors>Chen X</pubmed_authors><pubmed_authors>Li R</pubmed_authors><pubmed_authors>Li K</pubmed_authors><pubmed_authors>Pan K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Migrasomes constrained by a homologous-targeting photodynamic nanoplatform: enhancing intratumoral CD8&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; T-cell-associated antitumor immunity in oral squamous cell carcinoma.</name><description>Photodynamic therapy (PDT) is an effective adjunct treatment for oral squamous cell carcinoma (OSCC). Enhancing photosensitizer targeting and inducing effective cytotoxic T-cell responses through photoimmunotherapy have become key strategies to improve PDT efficacy. Migrasomes, as vesicular structures assembled by TSPAN4 and cholesterol microdomains, are implicated in immune escape and are emerging as sensitization targets for PDT. Here, we report a biomimetic nanoplatform, MOF-919@CCM, that combines enhanced tumor-cell membrane adhesion with light-controlled cholesterol degradation. Cloaking with a homologous cancer-cell membrane (CCM) imparts specific adhesion to tumor cells and improves targeted delivery of the photosensitizer. Moreover, the transition-metal nodes of MOF-919 exhibit per</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-07-16T10:03:13.361Z</modification><creation>2026-07-09T10:48:19.373Z</creation></dates><accession>S-EPMC12918463</accession><cross_references><pubmed>41588398</pubmed><doi>10.1186/s12951-026-04037-6</doi></cross_references></HashMap>